UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
Dated July 23, 2007
Commission File Number 0-28564
QIAGEN N.V.
(Translation of registrant’s name into English)
Spoorstraat 50
5911 KJ Venlo
The Netherlands
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No x
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ________.
This Report on Form 6-K shall be deemed to be incorporated by reference into QIAGEN N.V.’s Registration Statement on Form F-4 (Registration No. 333-143791) filed with the Securities and Exchange Commission on June 15, 2007, as amended, and shall be part thereof from the date on which this Report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.
QIAGEN N.V.
Form 6-K
TABLE OF CONTENTS
| Item |
Page | |
| Other Information |
1 | |
| Signatures |
2 | |
| Exhibit Index |
3 | |
OTHER INFORMATION
On July 23, 2007, QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) (“QIAGEN”) issued a press release announcing that, pursuant to its previously announced merger agreement with Digene Corporation (Nasdaq: DIGE) (“Digene”), its offer to exchange cash and stock for all outstanding shares of Digene expired as scheduled at 11:59 p.m., New York City time, on Friday, July 20, 2007. All conditions to the exchange offer having been either satisfied or waived, QIAGEN announced its intent to accept all tendered shares, which preliminary tabulations indicate constitute well in excess of 90% of Digene’s outstanding stock. The press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein.
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
QIAGEN N.V.
By: /s/ Peer M. Schatz
Peer M. Schatz
Chief Executive Officer
Date: July 23, 2007
2
EXHIBIT INDEX
| Exhibit No. | Exhibit | |
| 99.1 | Press Release dated July 23, 2007 |
3